Paradigm Asset Management’s NPS PHARMACEUTICALS INC NPSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-27,500
Closed -$984K 884
2014
Q4
$984K Sell
27,500
-1,100
-4% -$32.8K 0.13% 194
2014
Q3
$744K Buy
28,600
+2,100
+8% +$60.3K 0.1% 209
2014
Q2
$876K Buy
26,500
+3,800
+17% +$110K 0.12% 201
2014
Q1
$679K Sell
22,700
-1,700
-7% -$58.6K 0.09% 243
2013
Q4
$741K Sell
24,400
-1,400
-5% -$38.6K 0.11% 222
2013
Q3
$821K Sell
25,800
-3,100
-11% -$71.1K 0.13% 192
2013
Q2
$436K Buy
+28,900
New +$400K 0.07% 315

Other funds holding NPSP

Paradigm Asset Management's NPSP Position: Q1 2015 in Review

Paradigm Asset Management sold out of NPS PHARMACEUTICALS INC (NPSP) in Q1 2015, closing a stake of 27,500 shares — an estimated $984K sold.

Paradigm Asset Management first reported a position in NPSP in Q2 2013 and held it in 7 quarters. The position peaked at $984K in Q4 2014. 1 fund tracked by Wall St. Rank holds NPSP as of Q1 2015.

  • Paradigm Asset Management reported no remaining NPS PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • Paradigm Asset Management sold 27,500 NPS PHARMACEUTICALS INC shares in Q1 2015, an estimated $984K.
  • Paradigm Asset Management first reported a position in NPS PHARMACEUTICALS INC in Q2 2013 and held it in 7 quarters.
  • Paradigm Asset Management's NPS PHARMACEUTICALS INC position peaked at $984K in Q4 2014.
  • 1 fund tracked by Wall St. Rank held NPS PHARMACEUTICALS INC as of Q1 2015.

Based on Paradigm Asset Management's 13F filing for Q1 2015, filed 14 May 2015.